On Tuesday, May 6, 2025, the Pennsylvania House of Representatives voted to pass a bill proposal that would have legalized cannabis in the state for adults 21 years old and older. The legislation was introduced on May 4, 2025, and advanced from the House Health Committee the next day. The proposal passed 102-101. All republicans voted against the bill, while democrats voted in support of its passing. The bill advanced to the Senate where it unfortunately did not pass.

During a special legislative session, that was ordered by Texas Governor Greg Abbott, a bill called HB 195 was introduced by state Representative Jessica González, that would legalize adult-use cannabis in the state. If passed, aside from legalization, adults who are 21 years old and older would be entitled to possess 2.5 ounces of cannabis flower in public. At home, individuals would be allowed to have in their possession, 10 ounces of cannabis flower and 15 g of concentrates.

To get the cannabis industry up and running the Texas Department of Licensing and Regulation (DLR) would establish cannabis production and sales regulations. Additionally, the DLR would in charge of handling licenses for retailers, testing facilities, cultivators, processors, and transporters. Licensing would be anticipated to begin around November 1, 2026.

Colorado Attorney General Phil Weiser announced that a settlement had been reached involving the manufacturers and distributors of the 1906 brand of cannabis products, as well as Peter Barsoom, one of the co-founders. The settlement comes after an investigation was conducted and discovered that the companies “failed to disclose health risks associated with the products to consumers and misrepresented the products’ health benefits.”

On August 13, 2025, Dustin Sulak, an osteopathic general practitioner, founder of Healer, a cannabis education and product resource, presented the latest installment of the monthly webinar series that began in 2018. This month’s webinar focused on cannabinoids for sleep, sleep apnea, and the potential effect of inflammation.

On August 13, 2025, Dustin Sulak, an osteopathic general practitioner, founder of Healer, a cannabis education and product resource, presented the latest installment of the monthly webinar series that began in 2018. This month’s webinar focused on cannabinoids for sleep, sleep apnea, and the potential effect of inflammation. Here we present a summary of the first three out of seven studies presented in this webinar.

Virginia Governor Glenn Youngkin recently vetoed HB 1989, a medical cannabis bill which aimed to help make improvements to product labeling for medical cannabis products as well as “codify permissible delivery locations.” With the bill no longer able to become law, the Virginia Cannabis Control Authority regulations will now be taken into effect. These include decreasing access for medical cannabis patients. Medical cannabis will only be allowed to be delivered to the patient’s residence.

SB 2514 was recently signed into law by Florida Governor Ron DeSantis. The bill establishes that the state of Florida can revoke medical cannabis cards licensed in the Sunshine State for individuals that have been convicted of drug-related crimes. The Florida Department of Health will be able to “revoke the medical marijuana use registry registration of qualified patients and caregivers who enter certain pleas or are found guilty of certain offenses.”

A recent survey conducted by non-profit group, Mission Roll Call, called the “2025 VA Cuts & Services Survey” found that military veterans and their family members believe that the “Department of Veterans Affairs (VA) should provide medical cannabis treatment to eligible patients”

The survey consisted of approximately 2,000 veterans and their family members. 95% of survey respondents were a veteran or family member of a veteran and included responses from all 50 states in the US. According to survey results, 57% of respondents felt that they supported the VA to provide medical cannabis as a treatment option. 27% of respondents supported psychedelics, for example MDMA and psilocybin, as treatments the VA should support and 17% believed the VA should support Ketamine as another form of treatment for eligible patients.

With every new year, brings new changes. To start off 2025, the state of Louisiana enacted new legislation regarding tetrahydrocannabinol (THC) and cannabidiol (CBD) products. In the Bayou State, beginning on January 1, 2025, THC and CBD items have had their amounts lowered to 5 mg. Previously, these products were allowed to contain these cannabinoids at 8 mg. Additionally in the new year, gas stations have been banned from selling these types of products and the age limit to purchase cannabis has been raised to the age of 21.

Flavoalkaloids have been detected in cannabis leaves for the first time, a new study explains, noting that phenolic compounds are associated with health benefits. Flavoalkaloids are a group of secondary metabolites that are present in plants but are less common that flavonoids, it explains. The study, “Comprehensive two-dimensional liquid chromatographic analysis of Cannabis phenolics and first evidence of flavoalkaloids in Cannabis,” was published in the Journal of Chromatography A in May 2025.

Stay tuned for more news, articles, blogs, and more in 2026!